Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/76788
| Title: | Site-directed pegylation of arginases and the use thereof as anti-cancer and anti-viral agents | Authors: | Leung, YC Lo, WH |
Issue Date: | 5-Jul-2016 | Source: | US Patent 9,382,525 B2. Washington, DC: US Patent and Trademark Office, 2016. | Abstract: | The present invention provides a site-specific pegylated arginase conjugate and method for producing thereof. The site-specific pegylated arginase is homogeneous in molecular weight and shows therapeutic effect for treating cancers and viral infections. The method for producing the arginase conjugate comprises genetically modifying the gene encoding an arginase so that the PEG moiety can be attached to the enzyme at a predetermined, specific intended sites. This is achieved by removing the PEG-attaching amino acid residue(s) at undesirable site(s) while keeping or adding cysteine(s) at the desirable site(s) of the enzyme. Two exemplary embodiments of the pegylated arginase conjugate are directed to human arginase I (HAI) where a polyethylene glycol (PEG) moiety is site-specific covalently bonded to Cys.sup.45 of the enzyme and Bacillus caldovelox arginase (BCA) where a polyethylene glycol (PEG) moiety is site-specific covalently bonded to Cys.sup.161 of the enzyme. | Rights: | Assignee: The Hong Kong Polytechnic University |
| Appears in Collections: | Patent |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| us9382525b2.pdf | 4.56 MB | Adobe PDF | View/Open |
Page views
85
Last Week
0
0
Last month
Citations as of Jun 4, 2023
Downloads
28
Citations as of Jun 4, 2023
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.